APUS NYSE · Healthcare · FY 2025-12-31

Apimeds Pharmaceuticals US, Inc.

0.03.36.69.913.2ABVfair 12.19buy ≤ 4.27EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 5.15 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Wait
Buy zone
Fair–Wait
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
5.150 USD
Market cap
64.8M USD
P / B
0.42
P / E
EPS
-0.550
DPS / yield
(0.0%)
NAV / share
12.194
Graham number
Z'' score
14.55
Piotroski F
2 / 9
Beneish M
ROIC vs WACC
-3.3% vs 10.2%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.